Aspen Agrees to Buy Glaxo Products for 2.2 Billion Rand

Aspen Pharmacare Holdings Ltd., the Southern Hemisphere’s largest generic drugmaker, agreed to buy 25 pharmaceutical brands from U.K. partner GlaxoSmithKline Plc to bolster an Australian expansion.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.